B E Immuno Sciences Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 1999.
1999 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About B E Immuno Sciences Private Limited

B E Immuno Sciences Private Limited, a active private limited company, was established on 24 May 1999 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24230TG1999PTC031761. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Sridhar Pusapati Raju (Director), Mahima Datla (Director), Mantena Purnima (Additional Director). Past directors included Vijaykumar Datla. It holds ₹185.00 Cr open charges and ₹1.89 M settled loans. Its latest AGM occurred on 05 August 2024, with the balance sheet filed on 31 March 2024. It is based at 18/3, Azamabad, Hyderabad, Telangana, 500020.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TG1999PTC031761

  • Registration Number

    031761

  • Incorporation Date

    24 May 1999

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 26 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 185.00 Cr
  • Satisfied Charges ₹ 1.89 M
  • Revenue Growth **** 8.57%
  • Profit Growth **** -314.53%
  • Ebitda **** -148.30%
  • Net Worth -12.43%
  • Total Assets **** 90.03%
Company report

B E Immuno Sciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into B E Immuno Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at B E Immuno Sciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Sridhar Pusapati Raju Director 24 May 1999 Current
Mahima Datla Director 24 May 1999 Current
Mantena Purnima Additional Director 12 Apr 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 20 Mar 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of B E Immuno Sciences.

B E Immuno Sciences Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 8.57% increase. The company also saw a substantial fall in profitability, with a 314.53% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.43%.

B E Immuno Sciences revenue growth over time
B E Immuno Sciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 8.57%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 90.03%
*******
*******
*******
*******
Profit or Loss
*******
 -314.53%
*******
*******
*******
*******
Net Worth
*******
 -12.43%
*******
*******
*******
*******
EBITDA
*******
 -148.30%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of B E Immuno Sciences?

In 2021, B E Immuno Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,850,000,000.00

Satisfied Charges

₹1,892,000.00

Charges Breakdown by Lending Institutions
  • Others : 185.00 Cr
Latest Charge Details
Date Lender Amount Status
26 Jun 2024 Others ₹185.00 Cr Open
25 Nov 2011 Panjab National Bank ₹1.89 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at B E Immuno Sciences?

Unlock and access historical data on people associated with B E Immuno Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of B E Immuno Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B E Immuno Sciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on B E Immuno Sciences
Recent Activity within the Organization
  • Charges

    A charge with Others of Rs. 1,850.00 M registered on 26 Jun 2024 with Charge ID 100956429 was modified on 07 Oct 2024. was recorded as a recent event.

  • Annual General Meeting

    B E Immuno Sciences Private Limited last Annual general meeting of members was held on 05 Aug 2024 as per latest MCA records. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 1,850.00 M with Charge ID 100956429 was registered on 26 Jun 2024. was recorded as a recent event.

  • Balance Sheet

    The activity B E Immuno Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.

  • Charges

    The activity A charge registered on 25 Nov 2011 via Charge ID 10320893 with Panjab National Bank was fully satisfied on 28 Aug 2014. was completed.

  • Director Appointment

    The activity Mantena Purnima was appointed as a Additional Director was appointed as a Additional Director on 12 Apr 2013 & has been associated with this company since 12 years 9 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of B E Immuno Sciences Private Limited?

The CIN of B E Immuno Sciences Private Limited is U24230TG1999PTC031761.

Where is B E Immuno Sciences Private Limited headquartered?

B E Immuno Sciences Private Limited is headquartered at 18/3, Azamabad, Hyderabad, Telangana, 500020.

When was B E Immuno Sciences Private Limited incorporated?

B E Immuno Sciences Private Limited was incorporated on 24 May 1999.

Who are the current directors of B E Immuno Sciences Private Limited?

The current directors of B E Immuno Sciences Private Limited are

What is the primary industry of B E Immuno Sciences Private Limited?

The primary industry of B E Immuno Sciences Private Limited is Pharma.

Is B E Immuno Sciences Private Limited a listed company?

B E Immuno Sciences Private Limited is unlisted.

What is the capital structure of B E Immuno Sciences Private Limited?

The authorized capital of B E Immuno Sciences Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of B E Immuno Sciences Private Limited?

The compliance status of B E Immuno Sciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available